Dr. David Michael Nanus, M.D. of Weill Cornell Medicine discusses new recently discovered novel targets for CCRPC at ASCO GU 2016 in San Francisco.
Advertisement Single Below Content
Advertisement Single Below Content
Advertisement Single Below Content